Table 1. Rates of Bleeding Complications in the TIMI 10B Trial
|
Drug
|
n=
|
ICH
(%)
|
Total
Stroke (%)
|
Death
(%)
|
Serious
Bleeds (%)
|
|
Tenecteplase
30 mg
|
308
|
1
|
1.9
|
3.6
|
1.9
|
|
Tenecteplase
40 mg
|
154
|
1.9
|
2.6
|
6.5
|
5.2
|
|
Tenecteplase
50 mg
|
78
|
3.8
|
5.1
|
3.8
|
11.5
|
|
t-PA
front-loaded
|
316
|
1.9
|
2.8
|
5.7
|
8.5
|